Children in England will no longer be prescribed puberty blockers at gender identity clinics, according to the country’s National Health Service (NHS).
In a policy document released Tuesday, the NHS said that following a review of published research, “we have concluded that there is not enough evidence to support the safety or clinical effectiveness of [puberty suppressing hormones] to make the treatment routinely available at this time.”
Under the new policy, puberty blockers for those under 18 will only be available as part of research studies. One such study is slated to begin by the end of 2024.
Puberty blockers are hormone therapy
